Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Gynecology

  Free Subscription


07.07.2025

4 Acta Obstet Gynecol Scand
1 AJR Am J Roentgenol
8 Am J Obstet Gynecol
10 BMC Cancer
1 BMJ
1 Br J Radiol
1 Cancer Lett
1 Eur J Cancer
9 Eur J Obstet Gynecol Reprod Biol
2 Fertil Steril
1 Gynecol Endocrinol
5 Gynecol Oncol
2 Hum Reprod
8 Int J Gynaecol Obstet
2 Int J Oncol
1 J Clin Endocrinol Metab
1 JAMA
6 Obstet Gynecol
3 PLoS One
1 Urol Clin North Am
1 Urology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Obstet Gynecol Scand

  1. CHEN A, Wang D, Zhang Y, Dai Q, et al
    A comparative study on infant growth between assisted reproductive technology pregnancy and natural pregnancy.
    Acta Obstet Gynecol Scand. 2025 Jun 30. doi: 10.1111/aogs.15178.
    PubMed         Abstract available

  2. GYLLENBERG F, Brandell K, Jar-Allah T, Kallner HK, et al
    Differences in pain, bleeding, and satisfaction during medical abortion at very early gestations.
    Acta Obstet Gynecol Scand. 2025 Jul 2. doi: 10.1111/aogs.15177.
    PubMed         Abstract available

  3. NIJJAR S, Bottomley C, Jurkovic D
    A call for deeper insights into intramural pregnancy: An international data registry.
    Acta Obstet Gynecol Scand. 2025 Jul 2. doi: 10.1111/aogs.70007.
    PubMed         Abstract available

  4. TIRUNEH SA, Rolnik DL, Selvaratnam R, da Silva Costa F, et al
    External validation of the Fetal Medicine Foundation model for preterm pre-eclampsia prediction at 11-14 weeks in an Australian population.
    Acta Obstet Gynecol Scand. 2025 Jul 2. doi: 10.1111/aogs.70002.
    PubMed         Abstract available


    AJR Am J Roentgenol

  5. RAICHANDANI S
    Saying the Same Thing: Why Terminology Matters in Multidisciplinary Cervical Cancer Care.
    AJR Am J Roentgenol. 2025 Jul 2. doi: 10.2214/AJR.25.33449.
    PubMed        


    Am J Obstet Gynecol

  6. YANG Y, Guo P, Liu Y
    Postpartum Ibuprofen in Severe Hypertensive Disorders of Pregnancy: a comment.
    Am J Obstet Gynecol. 2025 Jun 27:S0002-9378(25)00428.
    PubMed        

  7. WEI S, Chen J, Yu L
    Concerns Regarding "Effect of Aspirin on Biomarker Profile in Women at High Risk for Preeclampsia".
    Am J Obstet Gynecol. 2025 Jun 27:S0002-9378(25)00439.
    PubMed        

  8. NGUYEN-HOANG L, Poon LC
    Effect of aspirin on biomarker profile in women at high-risk for preeclampsia: a reply.
    Am J Obstet Gynecol. 2025 Jun 27:S0002-9378(25)00440.
    PubMed        

  9. PUTTASWAMY RG, Maurya DK, Subbaiah M, Gupta A, et al
    Comparison of Two Different Dosing Regimens of Vaginal Misoprostol for Cervical Priming Among Women Undergoing Vaginoscopic Hysteroscopy: A Non-inferiority Randomized Controlled Trial.
    Am J Obstet Gynecol. 2025 Jun 27:S0002-9378(25)00443.
    PubMed         Abstract available

  10. NIETO-CALVACHE AJ, Basanta N, Palacios-Jaraquemada JM, Rivera-Torres LF, et al
    Vaginal Clamping of Uterine Arteries: A Temporary Intervention to Stop Bleeding in Postpartum Hemorrhage.
    Am J Obstet Gynecol. 2025 Jun 28:S0002-9378(25)00446.
    PubMed         Abstract available

  11. SHARMA N, MacGibbon KW, Brecht-Doscher A, Cortessis VK, et al
    Pre-pregnancy metformin use associated with lower risk of severe nausea and vomiting of pregnancy and hyperemesis gravidarum.
    Am J Obstet Gynecol. 2025 Jun 28:S0002-9378(25)00441.
    PubMed         Abstract available

  12. JACKSON FI, Dilena NJ, Ableman SH, Blitz MJ, et al
    Hemorrhage Management using a Foley Catheter for Uterine Suction.
    Am J Obstet Gynecol. 2025 Jun 30:S0002-9378(25)00447.
    PubMed         Abstract available

  13. JUDAH HR, Rigby RA, Stasinopoulos MD, Pateras K, et al
    Reference ranges for liver function tests in pregnancy controlling for maternal characteristics.
    Am J Obstet Gynecol. 2025 Jul 1:S0002-9378(25)00442.
    PubMed         Abstract available


    BMC Cancer

  14. IROWA O, Adeyeye OS, Ujah OI, Ogwuche PE, et al
    Assessment of barriers to cervical cancer screening at primary health care centers in Makurdi, North-Central Nigeria: a mixed-methods study.
    BMC Cancer. 2025;25:1099.
    PubMed         Abstract available

  15. DANG C, Wang R, Shi Y, Liu P, et al
    Genetically proxied therapeutic effect of antihypertensive drug use, breast cancer, and ovarian cancer's risk: a drug-target Mendelian randomization study.
    BMC Cancer. 2025;25:1125.
    PubMed         Abstract available

  16. LEMAN R, Cherifi F, Leheurteur M, Theret P, et al
    Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO).
    BMC Cancer. 2025;25:1075.
    PubMed         Abstract available

  17. TONGHUI B, Wufen L, Lin Q
    Single-cell sequencing reveals the role of SALL4 in cervical cancer development.
    BMC Cancer. 2025;25:1086.
    PubMed         Abstract available

  18. WANG M, Ye M, Lucero M, Pan W, et al
    Association of sodium-glucose cotransporter-2 inhibitor use and mortality in patients with endometrial cancer: a retrospective cohort study.
    BMC Cancer. 2025;25:1065.
    PubMed         Abstract available

  19. MANDIWA C, Sanna M, Gao W
    Cervical cancer screening uptake among women living with HIV in the era of universal test and treat policy in Malawi: results from the 2020-2021 Malawi population-based HIV impact assessment.
    BMC Cancer. 2025;25:1052.
    PubMed         Abstract available

  20. SEIFU BL, Asnake AA, Belayneh T, Hailemariam T, et al
    Individual and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Kenya demographic and health surveys 2022.
    BMC Cancer. 2025;25:1067.
    PubMed         Abstract available

  21. WU Y, Wang J, Fan Y, Wang J, et al
    Metabolic syndrome combined with insulin resistance showed great predictive value in evaluating recurrence in patients with atypical endometrial hyperplasia and early endometrial cancer.
    BMC Cancer. 2025;25:1094.
    PubMed         Abstract available

  22. SHARMA U, Yadav BK, Rai U, Pradhan A, et al
    Concordance between MRI and clinical examination in cervical cancer staging: a retrospective study.
    BMC Cancer. 2025;25:1098.
    PubMed         Abstract available

  23. COSTANZO S, Godino L, De Summa S, Marvulli TM, et al
    BRCA cascade counselling and testing in Italy: current position and future directions.
    BMC Cancer. 2025;25:1044.
    PubMed         Abstract available


    BMJ

  24. KAVANAGH J, Webb H
    Parliament takes a historic step toward decriminalising abortion-but the work isn't over.
    BMJ. 2025;389:r1348.
    PubMed        


    Br J Radiol

  25. HE J, Xu L, Chen Z, Chen C, et al
    Use of diffusion-weighted magnetic resonance imaging to distinguish between normal and small for gestational age pregnancies: comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient.
    Br J Radiol. 2025 Jun 23:tqaf136. doi: 10.1093.
    PubMed         Abstract available


    Cancer Lett

  26. DOGRA S, Elayapillai SP, Qu D, Pitts K, et al
    Corrigendum to "Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer" [Cancer Lett. 2023 Dec 1;578:216437].
    Cancer Lett. 2025 Jul 2:217889. doi: 10.1016/j.canlet.2025.217889.
    PubMed        


    Eur J Cancer

  27. LEDERMANN JA, Oza AM, Lorusso D, Aghajanian C, et al
    Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial.
    Eur J Cancer. 2025;225:115584.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  28. BIRENE B, Personne S, Gerin H, Maurice O, et al
    Background and safety of surgical abortion between 14 and 16 weeks gestation: A retrospective multicentre observational study.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114541.
    PubMed         Abstract available

  29. ARICA G, Yilmaz I, Kucuksuleymanoglu D, Davutoglu EA, et al
    Fetal pancreas measurements and the impact of gestational diabetes mellitus and fetal growth restriction.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114548.
    PubMed         Abstract available

  30. DITTO A, Fucina S, Chiarello G, Bogani G, et al
    Corrigendum to "An effective surgical approach to treat obese patients with gynecological disease using a subcutaneous abdominal wall-retraction device to perform low-pressure laparoscopy: A prospective, single-center study" [Eur. J. Obstetr. Gynecol.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114537.
    PubMed        

  31. WOLDER D, Blazuk-Fortak A, Gora T, Michalska A, et al
    The role of three-dimensional printed models of fetuses obtained from ultrasonographic examinations in obstetrics: clinical and educational aspects.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114538.
    PubMed         Abstract available

  32. OLIVEIRA AMADOR WF, Saraiva CA, Ruelas MG, Queiroz I, et al
    Pharmacological Treatments for Menopausal Vasomotor Symptoms: A Systematic Review and Bayesian Network Meta-Analysis of Efficacy and Safety.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114552.
    PubMed         Abstract available

  33. PIERROT B, Petit A, Gentil A, Molle-Guiliani B, et al
    Management of forced smoking cessation among pregnant smokers because of the smoking ban at maternity hospitals in Pays de la Loire.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114551.
    PubMed         Abstract available

  34. JIMENEZ RAMIREZ N, Panelli D, Padron E, Veliz-Dominguez L, et al
    Associations of adverse childhood experiences (ACE) with pregnancy outcomes in people with cardiac disease.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114547.
    PubMed         Abstract available

  35. AKSAN A, Ozkan S, Sucu S, Kurt D, et al
    Serum spexin levels as a biomarker for hyperemesis gravidarum: a case-control study.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114558.
    PubMed         Abstract available

  36. TROTTA L, Mascolo R, Mardygan V, Cercek AC, et al
    Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: A case series.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114553.
    PubMed         Abstract available


    Fertil Steril

  37. GRACIANO-ESPANA MDC, Barnhart K, Gonzalez-Monfort M, Arenas-Barrero M, et al
    Fusobacterium nucleatum is not significantly present in eutopic endometrium from patients with minimal-mild and moderate-severe endometriosis.
    Fertil Steril. 2025 Jun 28:S0015-0282(25)00540.
    PubMed         Abstract available

  38. ZHAO W, Guo Y, Zhou C, Sun P, et al
    Optimizing In Vitro Maturation Outcomes of Oocytes Following Gonadotropin Priming in Premenarcheal Girls Undergoing Ovarian Tissue Cryopreservation.
    Fertil Steril. 2025 Jun 28:S0015-0282(25)00543.
    PubMed         Abstract available


    Gynecol Endocrinol

  39. LIPING W, Chenyue T, Shuai C, Liu G, et al
    circRNA_BMPR2 affects the progression of polycystic ovary syndrome by regulating the expression of Rab43.
    Gynecol Endocrinol. 2025;41:2526559.
    PubMed         Abstract available


    Gynecol Oncol

  40. GREENMAN M, Bellone S, Demirkiran C, Hartwich TMP, et al
    Datopotamab deruxtecan, a novel TROP2-tareting antibody-drug conjugate with a topoisomerase I inhibitor payload, shows preclinical activity against primary and metastatic uterine and ovarian TROP2 over-expressing carcinosarcoma.
    Gynecol Oncol. 2025;199:64-71.
    PubMed         Abstract available

  41. DZYUBAK O, Glass K, Watts M, Tarafdar O, et al
    Oncologic and fertility outcomes of progestin therapy for atypical hyperplasia and grade 1 cancer of the endometrium: Results of a specialized oncofertility program.
    Gynecol Oncol. 2025;199:72-78.
    PubMed         Abstract available

  42. LINDEMANN K, Berton D, Sehouli J, Christensen RD, et al
    NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer.
    Gynecol Oncol. 2025;199:79-87.
    PubMed         Abstract available

  43. RANDALL L, Xiang Y, Matsumoto T, Giannarelli D, et al
    Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer.
    Gynecol Oncol. 2025;199:88-95.
    PubMed         Abstract available

  44. HARDESTY MM, Krivak TC, Wright GS, Hamilton E, et al
    A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIO.
    Gynecol Oncol. 2025;199:96-102.
    PubMed         Abstract available


    Hum Reprod

  45. DUNBAR S, Dhillon-Smith R, Maheshwari A
    Thyroid function testing prior to fertility treatment: will we ever agree?
    Hum Reprod. 2025;40:1243-1248.
    PubMed         Abstract available

  46. IANNATTONE S, Rapisarda M, Bottesi G, Cerea S, et al
    Exploring positive and negative body image and health-related quality of life in women with endometriosis: a latent profile analysis.
    Hum Reprod. 2025 Jul 1:deaf127. doi: 10.1093.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  47. CHHABRA S, Kumar N
    Water intake and its relation with oligohydramnios and vaginal bleeding among low resource, rural pregnant women: a community based observational study.
    Int J Gynaecol Obstet. 2025 Jun 28. doi: 10.1002/ijgo.70341.
    PubMed         Abstract available

  48. VITEAU E, Roy M, Delotte J, Gauci PA, et al
    Evaluation of endometriosis patients' expectations of a therapeutic patient education program and comparison with practitioners' perception.
    Int J Gynaecol Obstet. 2025 Jun 30. doi: 10.1002/ijgo.70349.
    PubMed         Abstract available

  49. ETRUSCO A, Agrifoglio V, Chiantera V, Lagana AS, et al
    Efficacy, safety, and feasibility of the treatment of intrauterine pathologies with the hysteroscopic morcellator: A systematic review.
    Int J Gynaecol Obstet. 2025 Jul 1. doi: 10.1002/ijgo.70347.
    PubMed         Abstract available

  50. LI Y, Xuan L, Wang Q
    Primary squamous cell carcinoma of the uterine wall associated with adenomyosis: A rare case report and literature review.
    Int J Gynaecol Obstet. 2025 Jul 1. doi: 10.1002/ijgo.70353.
    PubMed         Abstract available

  51. BARTELS HC, Fox KA, Aryananda RA, Terlizzi K, et al
    Patient centered care for placenta accreta spectrum: Exploring implementation of recommendations based on reported patient and healthcare provider experiences.
    Int J Gynaecol Obstet. 2025 Jul 1. doi: 10.1002/ijgo.70345.
    PubMed         Abstract available

  52. HUANG Y, Yao J, Zhao Y, Chen M, et al
    Distinct response to treatment and characteristics of bile acid composition of early- and late-onset intrahepatic cholestasis of pregnancy: A prospective pilot study.
    Int J Gynaecol Obstet. 2025 Jul 2. doi: 10.1002/ijgo.70247.
    PubMed         Abstract available

  53. LI M, Xu S, Yang Q, Zheng Z, et al
    Epidemiological trends of gynecologic cancer burden in east Asian countries from 1990 to 2021 and projections to 2031.
    Int J Gynaecol Obstet. 2025 Jul 4. doi: 10.1002/ijgo.70351.
    PubMed         Abstract available

  54. RUGERI L, Fruchou Y, Brodbeck C, Bastien M, et al
    Evaluation of coagulation disorders and iron deficiency in women with heavy menstrual bleeding.
    Int J Gynaecol Obstet. 2025 Jul 4. doi: 10.1002/ijgo.70352.
    PubMed         Abstract available


    Int J Oncol

  55. KAUSAR MA, Alshammari KF, Alenazi F, Anwar S, et al
    RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review).
    Int J Oncol. 2025;67:65.
    PubMed         Abstract available

  56. LIU R, Martin TA, Jordan NJ, Ruge F, et al
    [Corrigendum] Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis.
    Int J Oncol. 2025;67:64.
    PubMed         Abstract available


    J Clin Endocrinol Metab


  57. Correction to: "Effective Brief, Low-impact, High-intensity Osteogenic Loading in Postmenopausal Osteoporosis".
    J Clin Endocrinol Metab. 2025 Jun 24:dgaf354. doi: 10.1210.
    PubMed        


    JAMA

  58. ANDERER S
    Collection Kits Boost Cervical Cancer Screening.
    JAMA. 2025 Jul 2. doi: 10.1001/jama.2025.10322.
    PubMed        


    Obstet Gynecol

  59. QIAO E, Burns H, Rodriguez MI, Cichowski SB, et al
    Urinary Incontinence and Menopausal Symptom Burden.
    Obstet Gynecol. 2025 Jul 3. doi: 10.1097/AOG.0000000000005994.
    PubMed         Abstract available

  60. TAMATE M, Testa G, Divine L, Bayer J, et al
    Living Donor Uterus Transplantation.
    Obstet Gynecol. 2025 Jul 3. doi: 10.1097/AOG.0000000000005987.
    PubMed         Abstract available

  61. MCLAUGHLIN MM, Lee C, Ghaffari N, Gonzalez Velez JM, et al
    National Trends in Prepregnancy Cardiometabolic Risk and Counseling: An Analysis of the Pregnancy Risk Assessment Monitoring System, 2016-2022.
    Obstet Gynecol. 2025 Jul 3. doi: 10.1097/AOG.0000000000005990.
    PubMed         Abstract available

  62. APELIAN S, Vest A, Yasukawa M, Wellcome J, et al
    Uterine Transposition for Fertility Preservation and Ovarian Conservation in Patients Undergoing Pelvic Radiotherapy.
    Obstet Gynecol. 2025 Jul 3. doi: 10.1097/AOG.0000000000005954.
    PubMed         Abstract available

  63. BELAK L, James K, Rana M, Viscosi V, et al
    Association of Health-Related Social Needs With Adverse Pregnancy Outcomes Among Black and Latina Individuals.
    Obstet Gynecol. 2025 Jul 3. doi: 10.1097/AOG.0000000000005999.
    PubMed         Abstract available

  64. PONDUGULA N, Culhane JF, Lundsberg LS, Partridge C, et al
    Gestational Weight Gain and Hypertensive Disorders of Pregnancy With Prepregnancy and Early Pregnancy Glucagon-Like Peptide-1 Receptor Agonist Exposure.
    Obstet Gynecol. 2025 Jul 3. doi: 10.1097/AOG.0000000000005995.
    PubMed         Abstract available


    PLoS One

  65. MERHI Z, Karekar M, Mouanness M
    GLP-1 receptor agonist for weight loss and fertility: Social media and online perception versus evidence-based medicine.
    PLoS One. 2025;20:e0326210.
    PubMed         Abstract available

  66. ZAKI RM, Aldosari BN, Alkharashi LA, Alsalhi A, et al
    Fabrication and appraisal of axitinib loaded PEGylated spanlastics against MCF- 7 and OV- 2774 cell lines using molecular docking methods and in-vitro study.
    PLoS One. 2025;20:e0325055.
    PubMed         Abstract available

  67. SAJO AE, Mnisi EF, Bassa S, Visser C, et al
    Clinico-pathological and treatment characteristics of HIV and non-HIV related vulvar cancers: Analysis of a South African cohort.
    PLoS One. 2025;20:e0327119.
    PubMed         Abstract available


    Urol Clin North Am

  68. MIHALO JR, Semins MJ
    Stone Disease in Pregnancy.
    Urol Clin North Am. 2025;52:441-449.
    PubMed         Abstract available


    Urology

  69. GRIMSBY GM
    Editorial Comment on "Characterization of Female Urologists' Pregnancy, Perinatal and Breastfeeding Outcomes".
    Urology. 2025 Jun 14:S0090-4295(25)00593-X. doi: 10.1016/j.urology.2025.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.